STANDARD BIOTOOLS INC. — Director's Dealing 2011

Feb 17, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-02-15

Reporting Person: EuclidSR Partners, L.P. (10% Owner)
Reporting Person: EuclidSR Biotechnology Partners, L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-15	Common Stock	C	47400	—	Acquired	47400.00	Indirect
2011-02-15	Common Stock	C	320063	—	Acquired	367463.00	Indirect
2011-02-15	Common Stock	C	66991	—	Acquired	434454.00	Indirect
2011-02-15	Common Stock	C	47400	—	Acquired	481854.00	Indirect
2011-02-15	Common Stock	C	320063	—	Acquired	801917.00	Indirect
2011-02-15	Common Stock	C	66991	—	Acquired	868908.00	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-15	Series E Preferred Stock	$	C	47400	Disposed		Common Stock (47400)	Indirect
2011-02-15	Series C Preferred Stock	$	C	320063	Disposed		Common Stock (320063)	Indirect
2011-02-15	Series D Preferred Stock	$	C	66991	Disposed		Common Stock (66991)	Indirect
2011-02-15	Series E Preferred Stock	$	C	47400	Disposed		Common Stock (47400)	Indirect
2011-02-15	Series C Preferred Stock	$	C	320063	Disposed		Common Stock (320063)	Indirect
2011-02-15	Series D Preferred Stock	$	C	66991	Disposed		Common Stock (66991)	Indirect

Footnotes

F1: Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for-1.300053676865 basis.

F2: Not applicable.

F3: EuclidSR Partners, L.P., is the record holder of the securities reported.

F4: These securities are owned of record by EuclidSR Partners, L.P., for which voting and investment power is shared by Graham D.S. Anderson, Milton J. Pappas, Stephen K. Reidy and Raymond J. Whitaker, each of whom is a general partner of EuclidSR Associates, L.P., the general partner of EuclidSR Partners, L.P. Raymond J. Whitaker, a member of the Board of Directors of the Issuer, and each of the other general partners of EuclidSR Associates, L.P. discliams beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F5: Represents shares of Common Stock issued upon the conversion of shares of Series C Preferred Stock or Series D Preferred Stock on a 1-for-1 basis.

F6: EuclidSR Biotechnology Partners, L.P. is the record holder of the securities reported.

F7: Each share of Series E Preferred Stock automatically converted into 1.300053676865 share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offer (the "Closing) and has no expiration date.

F8: Each share of Series C Preferred Stock or Series D Preferred Stock automatically converted into one share of Common Stock on the Closing and has no expiration date.